L
Título: Pathways for proton release during ubihydroquinone oxidation by the bc1 complex
Autores: Crofts, Antony R.
Hong, Sangjin
Ugulava, Natalia
Barquera, Blanca
Gennis, Robert
Guergova-Kuras, Mariana
Berry, Edward A.
Fecha: 1999-08-31
Publicador: The National Academy of Sciences
Fuente: Ver documento
Ver documento
Tipo: Text
Tema: Biological Sciences
Descripción: Quinol oxidation by the bc1 complex of Rhodobacter sphaeroides occurs from an enzyme–substrate complex formed between quinol bound at the Qo site and the iron–sulfur protein (ISP) docked at an interface on cytochrome b. From the structure of the stigmatellin-containing mitochondrial complex, we suggest that hydrogen bonds to the two quinol hydroxyl groups, from Glu-272 of cytochrome b and His-161 of the ISP, help to stabilize the enzyme–substrate complex and aid proton release. Reduction of the oxidized ISP involves H transfer from quinol. Release of the proton occurs when the acceptor chain reoxidizes the reduced ISP, after domain movement to an interface on cytochrome c1. Effects of mutations to the ISP that change the redox potential and/or the pK on the oxidized form support this mechanism. Structures for the complex in the presence of inhibitors show two different orientations of Glu-272. In stigmatellin-containing crystals, the side chain points into the site, to hydrogen bond with a ring hydroxyl, while His-161 hydrogen bonds to the carbonyl group. In the native structure, or crystals containing myxothiazol or β-methoxyacrylate-type inhibitors, the Glu-272 side chain is rotated to point out of the site, to the surface of an external aqueous channel. Effects of mutation at this residue suggest that this group is involved in ligation of stigmatellin and quinol, but not quinone, and that the carboxylate function is essential for rapid turnover. H+ transfer from semiquinone to the carboxylate side chain and rotation to the position found in the myxothiazol structure provide a pathway for release of the second proton.
Idioma: en
Artículos similares:
BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite por Bernard-Gallon, Dominique J,Déchelotte, Pierre,Vissac, Cécile,Aunoble, Bénédicte,Cravello, Laetitia,Malpuech, Georges,Bignon, Yves-Jean
Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer por Lizard-Nacol, Sarab,Coudert, Bruno,Colosetti, Pascal,Riedinger, Jean-Marc,Fargeot, Pierre,Brunet-Lecomte, Patrick
Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system por Zujewski, JoAnne,Vaughn-Cooke, Anika,Flanders, Kathleen C,Eckhaus, Michael A,Lubet, Ronald A,Wakefield, Lalage M
Smoking and high-risk mammographic parenchymal patterns: a case-control study por Sala, Evis,Warren, Ruth,McCann, Jenny,Duffy, Stephen,Luben , Robert,Day, Nicholas
Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line por Annab, Lois A,Hawkins, Rebecca E,Solomon, Greg,Barrett, J Carl,Afshari, Cynthia A
10 
A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland por Gordon, Katrina E,Binas, Bert,Chapman, Rachel S,Kurian, Kathreena M,Clarkson, Richard W E,John Clark, A,Birgitte Lane, E,Watson, Christine J